{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:50:42Z","timestamp":1792144242317,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpet.2026.105035","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:14:53Z","timestamp":1790205293000},"page":"105035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leucine-rich repeat kinase 2 is involved in the microtubule-mediated regulation of intraocular pressure"],"prefix":"10.1016","volume":"393","author":[{"given":"Yuji","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-518X","authenticated-orcid":false,"given":"Reijiro","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpet.2026.105035_bib1","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202012095","article-title":"The cell biology of Parkinson's disease","volume":"220","author":"Panicker","year":"2021","journal-title":"J.Cell Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105035_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-019-0344-2","article-title":"LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same","volume":"14","author":"Berwick","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.jpet.2026.105035_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jnc.15240","article-title":"LRRK2 at the pre-synaptic site: A 16-year perspective","volume":"157","author":"Pischedda","year":"2021","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.jpet.2026.105035_bib4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.molmed.2024.07.003","article-title":"LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting","volume":"30","author":"Xiong","year":"2024","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jpet.2026.105035_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and Pathogenesis of Parkinson's Syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"22","key":"10.1016\/j.jpet.2026.105035_bib6","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/acschemneuro.4c00657","article-title":"LRRK2 Inhibitors as Promising Treatment for Parkinson\u2019s Disease","volume":"15","author":"Tan","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"10.1016\/j.jpet.2026.105035_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/19768354.2022.2158219","article-title":"LRRK2 decreases microglial actin dynamics by filamentous actin depolymerization and Rac1 inhibition","volume":"26","author":"Kim","year":"2022","journal-title":"Anim Cells Syst (Seoul)"},{"issue":"13","key":"10.1016\/j.jpet.2026.105035_bib8","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/s44319-025-00486-6","article-title":"LRRK2 interactions with microtubules are independent of LRRK2-mediated Rab phosphorylation","volume":"26","author":"Malankhanova","year":"2025","journal-title":"EMBO Rep"},{"issue":"10414","key":"10.1016\/j.jpet.2026.105035_bib9","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: Now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jpet.2026.105035_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2020.21899","article-title":"Glaucoma in Adults-Screening, Diagnosis, and management: a review","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpet.2026.105035_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221140392","article-title":"Current situation and progress of drugs for reducing intraocular pressure","volume":"13","author":"Liu","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jpet.2026.105035_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/milmed\/usz235","article-title":"Temporal effects of 2% pilocarpine ophthalmic solution on human pupil size and accommodation","volume":"185","author":"Kinney","year":"2020","journal-title":"Mil Med"},{"key":"10.1016\/j.jpet.2026.105035_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109444","article-title":"Identifying new drugs and targets to treat rapidly elevated intraocular pressure for angle closure and secondary glaucomas to curb visual impairment and prevent blindness","volume":"232","author":"Sharif","year":"2023","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jpet.2026.105035_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175882","article-title":"Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork","volume":"954","author":"Qin","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105035_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1091\/mbc.e10-03-0269","article-title":"Soluble levels of cytosolic tubulin regulate ciliary length control","volume":"22","author":"Sharma","year":"2011","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jpet.2026.105035_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fnins.2020.00443","article-title":"LRRK2 at the interface between peripheral and central immune function in Parkinson's","volume":"14","author":"Wallings","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jpet.2026.105035_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00376","article-title":"Multiple-hit hypothesis in Parkinson\u2019s disease: LRRK2 and inflammation","author":"Cabezudo","year":"2020","journal-title":"Front Neurosci"},{"issue":"7","key":"10.1016\/j.jpet.2026.105035_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/bioengineering9070310","article-title":"An \u03b12-adrenergic agonist, brimonidine, beneficially affects the TGF-\u03b22-treated cellular properties in an in vitro culture model","volume":"9","author":"Watanabe","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.jpet.2026.105035_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep19640","article-title":"Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jpet.2026.105035_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.12.12.4","volume":"12","author":"Debele","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"10.1016\/j.jpet.2026.105035_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1358\/dot.2020.56.9.3178110","article-title":"An update on ripasudil for the treatment of glaucoma and ocular hypertension","volume":"56","author":"Testa","year":"2020","journal-title":"Drugs Today (Barc)"},{"issue":"2","key":"10.1016\/j.jpet.2026.105035_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3390\/ijms23020742","article-title":"The role of cytoskeletal proteins in the formation of a functional in vitro Blood-Brain Barrier Model","volume":"23","author":"Mentor","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2026.105035_bib23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1471-4159.2009.06235.x","article-title":"Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability\u2014a point of convergence in parkinsonian neurodegeneration?","volume":"110","author":"Gillardon","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpet.2026.105035_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2012.12.019","article-title":"Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration","volume":"54","author":"Caesar","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.jpet.2026.105035_bib25","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1021\/acs.jmedchem.4c00520","article-title":"Concurrent optimizations of efficacy and blood-brain barrier permeability in new macrocyclic LRRK2 inhibitors for potential Parkinson\u2019s Disease therapeutics","volume":"67","author":"Kim","year":"2024","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.jpet.2026.105035_bib26","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1007\/s10620-024-08494-7","article-title":"Biphenotypic cells and alpha-synuclein accumulation in enteric neurons of leucine-rich repeat kinase 2 knockout mice","volume":"69","author":"Maekawa","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jpet.2026.105035_bib27","doi-asserted-by":"crossref","unstructured":"Kim JW, Yin X, Martin I, et al. eNeuro. 2020;8(6):ENEURO.0310-21.2021. doi: 10.1523\/ENEURO.0310-21.2021. Print 2021 Nov-Dec. PMID: 34759048. 2022;23(2):742.","DOI":"10.1523\/ENEURO.0310-21.2021"},{"key":"10.1016\/j.jpet.2026.105035_bib28","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","article-title":"LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice","volume":"20","author":"Herzig","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.jpet.2026.105035_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(82)90529-5","article-title":"Reduction in intraocular pressure induced by colchicine and related compounds","volume":"77","author":"Williams","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2026.105035_bib30","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/jamaneurol.2018.1885","article-title":"Frequency of Loss of function variants in LRRK2 in Parkinson disease","volume":"75","author":"Blauwendraat","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jpet.2026.105035_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-020-0893-5","article-title":"The effect of LRRK2 loss-of-function variants in humans","volume":"26","author":"Whiffin","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jpet.2026.105035_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-019-0344-2","article-title":"LRRK2 biology from structure to dysfunction: Research progresses, but the themes remain the same","volume":"14","author":"Berwick","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jpet.2026.105035_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","article-title":"Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson\u2019s disease","volume":"63","author":"Taylor","year":"2020","journal-title":"Curr Opin Cell Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:41:21Z","timestamp":1792143681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022356526012358"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105035","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leucine-rich repeat kinase 2 is involved in the microtubule-mediated regulation of intraocular pressure","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105035"}}